The National Hospital for Neurology and Neurosurgery
London, WC1N 3BG, United Kingdom
NCT Number: NCT02275000
The aim of this study is to develop and assess the feasibility of a physiotherapy intervention for people with functional motor symptoms (also known as psychogenic neurological symptoms and conversion disorder). Participants will be randomised to receive the intervention or a "treatment as usual" control.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
London, WC1N 3BG, United Kingdom
Participants will be recruited from outpatient neurology clinics at Queen Square. Those who consent to take part will complete baseline outcome measures (Time 1) before being randomised to either a Treatment as Usual control group or the Intervention group.
Treatment as Usual group -
A referral to community therapy for such patients is usual practice in the UK, although the form in which the community therapy is provided tends to be inconsistent across the UK. In most cases it will entail between 1 and 8 outpatient or domiciliary physiotherapy appointments. Some communities will have access to Occupational Therapy, which may entail supported practice and advice to increase independence with functional tasks and the provision of equipment. The provision of community therapy to participants will be monitored through the CSRI.
Intervention Group -
For participants allocated to the intervention group, a 5 day admission on the Day Hospital at the National Hospital for Neurology and Neurosurgery is arranged. The physiotherapy intervention will take place in the physiotherapy department. Participants will be admitted individually (and not in groups). Outside of physiotherapy times participants are encouraged to rest in the day hospital and complete a workbook. A single independent physiotherapist will be trained to deliver the intervention.
The participant (+/- family member) will attend an initial meeting with the consultant neurologist and the treating physiotherapist. The neurologist will perform a brief neurological assessment and confirm the diagnosis.
Both groups will be followed up at 6 months after recruitment to the study (Time 3). An independent assessor will administer the outcome measures.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The experimental group will complete a 5 day physiotherapy programme consisting of education, movement retraining and a self management plan.
Treatment as usual physiotherapy. The participant will be referred to their closest NHS outpatient neuro-physiotherapy service.
Time frame: Approximately 4 weeks after randomisation (this will be immediately after treatment for the experimental arm) and 6 months
Self rated 5 point Likert scale of change
Time frame: Baseline and 6 months
Time frame: Baseline, approximately 4 weeks after randomisation and 6 months
Time frame: Baseline, approximately 4 weeks after randomisation and 6 months
Time frame: Baseline, approximately 4 weeks after randomisation and 6 months
Time frame: Baseline, approximately 4 weeks after randomisation and 6 months
Time frame: Baseline, approximately 4 weeks after randomisation and 6 months
self reported questionnaire of upper limb function
Time frame: Baseline, approximately 4 weeks after randomisation and 6 months
Scale of assistance required when walking 5, 50 and 500 metres.
Time frame: Baseline, approximately 4 weeks after randomisation and 6 months
Blind video analysis of movement
Time frame: Baseline, approximately 4 weeks after randomisation and 6 months
Time frame: Baseline, approximately 4 weeks after randomisation and 6 months
timed walk over 10 metres
Time frame: Baseline and 6 month follow up
This questionnaire collects retrospective information about the use of health and social care services, income, employment and benefits. It can be used to calculate service costs and total costs of care.
University College, London
Other
Randomised Feasibility Study of a Physiotherapy Programme for Patients With Functional Motor Symptoms (FMS).
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02329626
Conversion Disorder, Mental Disorders
Montpellier, France
View Trial DetailsNCT05305014
Conversion Disorder, Mental Disorders
Nîmes, Choisir Une Région, France
View Trial DetailsNCT05219006
Conversion Disorder, Functional Neurological Symptom Disorder
Mexico City, Mexico
View Trial DetailsNCT03398070
Conversion Disorder, Mental Disorders
Boston, Massachusetts, United States
View Trial Details